During the past decade, Sofia Cancer Center compl. Mladost , conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Sofia Cancer Center compl. Mladost ," are "Gastrointestinal Stromal Tumors" (1 trials) and "Prostate Cancer" (1 trials). Many other conditions were trialed in "Sofia Cancer Center compl. Mladost ," in a lesser frequency.

Most popular intervention types in "Sofia Cancer Center compl. Mladost ," are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Glivec" (1 trials) and "Zometa" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sofia Cancer Center compl. Mladost ," are 1 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Sofia Cancer Center compl. Mladost ,". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Sofia Cancer Center compl. Mladost ,, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Sofia Cancer Center compl. Mladost ,, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".